<DOC>
	<DOCNO>NCT00971867</DOCNO>
	<brief_summary>The purpose study provide access paclitaxel therapy subject advance head neck cancer complete previous late phase 2 study ( CA139-388 ) continue therapy paclitaxel discretion investigator , evaluate frequency severity observe adverse reaction treat subject</brief_summary>
	<brief_title>Rollover Study Weekly Paclitaxel ( BMS-181339 ) Patients With Head Neck Cancer</brief_title>
	<detailed_description />
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Subjects advance head neck cancer complete previous late phase 2 study ( CA139388 ) continue therapy aclitaxel discretion investigator</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>